Avidity Biosciences
RNA
#3379
Rank
NZ$5.62 B
Marketcap
$46.77
Share price
-9.42%
Change (1 day)
5.45%
Change (1 year)

Avidity Biosciences (RNA) - Cash on Hand

Cash on Hand as of December 2024 : NZ$2.62 Billion

According to Avidity Biosciences's latest financial reports the company has NZ$2.62 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Avidity Biosciences - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$2.66 B182.8%
2023-12-31NZ$0.94 B-2.13%
2022-12-31NZ$0.96 B62.01%
2021-12-31NZ$0.59 B30.55%
2020-12-31NZ$0.45 B223.84%
2019-12-31NZ$0.14 B2948.48%
2018-12-31NZ$4.6 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$1.99 B-24.10%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$16.37 M-99.38%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.36 B-9.77%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.90 B-65.53%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.48 B-81.41%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$35.81 B 1,263.77%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$8.15 B 210.40%๐Ÿ‡ฌ๐Ÿ‡ง UK